OverviewChartProfileKey statisticsFinancialsNews
Derivatives
TraderScreen

ADVANCED MIC.DEV. DL-,01/  US0079031078  /

München
2024-12-20  3:54:38 PM Chg. -0.96 Volume Bid10:00:00 PM Ask10:00:00 PM Market Capitalization Dividend Y. P/E Ratio
114.16EUR -0.83% 9
Turnover: 1,027.44		 -Bid Size: - -Ask Size: - 185.5 bill.EUR - -
Newsfile Corp 12-10 Railtown AI Accepted into the AMD Partner Network to Accelerate AI-driven Innovation
TeleTrader 11-18 IBM unveils collaboration with AMD focused on AI
TeleTrader 11-13 AMD cuts 4% of its global workforce
Newsfile Corp 10-30 AI-powered Home Monitoring Data Presented at Academy 2024
TeleTrader 10-29 AMD's Q3 revenue jumps 18% to $6.8B
TeleTrader 10-29 Nasdaq surges 1% as tech sector leads gains
TeleTrader 10-29 US open mostly lower ahead of major earnings
TeleTrader 10-29 US mixed premarket ahead of big earnings
TeleTrader 10-17 TSMC hits record high, surging 13% on profit growth
TeleTrader 10-15 Nasdaq 100 drops by 1.3% on tech firms' losses
TeleTrader 10-10 US stocks fall at close after latest CPI print
TeleTrader 10-10 AMD unveils Ryzen AI PRO 300 Series processors for business PCs
TeleTrader 09-19 Dow rises 650 pts, tops 42K for first time after Fed cut
TeleTrader 09-19 Tesla shares up 5% amid broader tech rally after Fed rate cut
TeleTrader 09-11 Oracle exec: AMD bearing well in Nvidia-dominated chip market
TeleTrader 09-06 Dow loses 200 pts, Nasdaq slumps 2% on chips
GlobeNewswire 09-01 Belite Bio Announces Appointment of Hendrik P. N. Scholl, MD, MA, as Chief Medical Officer
GlobeNewswire 08-30 Opthea Reports Full-Year Financial Results and Business Updates
TeleTrader 08-28 Dow down by 350 pts with tech sector in focus
GlobeNewswire 08-28 PulseSight Therapeutics Confirms H2 2024 Conference Schedule
GlobeNewswire 08-27 4DMT to Host 4D-150 Wet AMD Development Day on September 18, 2024
GlobeNewswire 08-27 Clearside Biomedical Announces Completion of Final Participant Visit in ODYSSEY Phase 2b Trial of CL...
GlobeNewswire 08-27 EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences
GlobeNewswire 08-26 Aura Biosciences Announces the Presentation of Phase 2 End of Study Data Evaluating Suprachoroidal A...
GlobeNewswire 08-26 AGI to Showcase Its Latest Innovations at IFA 2024